STOCK TITAN

BeautyHealth Appoints Stephen J. Fanning to Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management

BeautyHealth (NASDAQ: SKIN) has appointed Stephen J. Fanning to its Board of Directors, effective December 12, 2024. Fanning, a medical aesthetics veteran and former Hydrafacial Chairman (2016-2020), brings extensive industry experience to the role. His previous positions include President and CEO of Spectrum Solutions, leadership at Z-Medica, Solta Medical, and Johnson & Johnson. He currently serves as Chairman for Champion Manufacturing and LKC Technologies.

Fanning will join both the Nominating & Corporate Governance Committee and the Audit Committee, bringing the total board membership to eight directors. BeautyHealth Executive Chairman Brent Saunders highlighted Fanning's expertise in medical aesthetics and proven track record in driving global growth as valuable assets for the company's future growth and profitability initiatives.

BeautyHealth (NASDAQ: SKIN) ha nominato Stephen J. Fanning nel suo Consiglio di Amministrazione, con effetto dal 12 dicembre 2024. Fanning, un veterano della medicina estetica e ex Presidente di Hydrafacial (2016-2020), porta un'ampia esperienza nel settore a questo ruolo. Le sue precedenti posizioni includono Presidente e CEO di Spectrum Solutions, ruoli di leadership in Z-Medica, Solta Medical e Johnson & Johnson. Attualmente ricopre il ruolo di Presidente per Champion Manufacturing e LKC Technologies.

Fanning entrerà a far parte sia del Comitato di Nominazione e Governance Aziendale che del Comitato di Revisione, portando il totale dei componenti del consiglio a otto direttori. Il Presidente Esecutivo di BeautyHealth, Brent Saunders, ha sottolineato l'expertise di Fanning nella medicina estetica e il suo comprovato record nel favorire la crescita globale come risorse preziose per le iniziative future di crescita e redditività dell'azienda.

BeautyHealth (NASDAQ: SKIN) ha designado a Stephen J. Fanning para su Junta Directiva, con efecto a partir del 12 de diciembre de 2024. Fanning, veterano en estética médica y ex presidente de Hydrafacial (2016-2020), aporta una amplia experiencia en la industria a este cargo. Sus puestos anteriores incluyen presidente y CEO de Spectrum Solutions, liderazgo en Z-Medica, Solta Medical y Johnson & Johnson. Actualmente, ejerce como presidente de Champion Manufacturing y LKC Technologies.

Fanning se unirá tanto al Comité de Nominaciones y Gobernanza Corporativa como al Comité de Auditoría, lo que eleva el número total de miembros de la junta a ocho directores. Brent Saunders, presidente ejecutivo de BeautyHealth, destacó la experiencia de Fanning en estética médica y su historial comprobado en impulsar el crecimiento global como activos valiosos para el futuro crecimiento y las iniciativas de rentabilidad de la empresa.

BeautyHealth (NASDAQ: SKIN)는 Stephen J. Fanning을 이사회에 임명했으며, 2024년 12월 12일부터 효력을 발휘합니다. Fanning은 의료 미용 분야의 베테랑이자 Hydrafacial의 전 의장(2016-2020)으로, 이 역할에 광범위한 산업 경험을 가져옵니다. 그의 이전 직책에는 Spectrum Solutions의 사장겸 CEO, Z-Medica, Solta Medical 및 Johnson & Johnson에서의 리더십이 포함됩니다. 그는 현재 Champion Manufacturing과 LKC Technologies의 의장직을 맡고 있습니다.

Fanning은 Nominating & Corporate Governance Committee와 Audit Committee 모두에 합류하여 이사회의 총 구성원을 여덟 명으로 늘립니다. BeautyHealth의 행정 의장인 Brent Saunders는 Fanning의 의료 미용 전문성과 글로벌 성장 촉진에 대한 입증된 실적이 회사의 미래 성장 및 수익성 이니셔티브에 귀중한 자산이라고 강조했습니다.

BeautyHealth (NASDAQ: SKIN) a nommé Stephen J. Fanning à son Conseil d'Administration, à compter du 12 décembre 2024. Fanning, vétéran de l'esthétique médicale et ancien président de Hydrafacial (2016-2020), apporte une vaste expérience de l'industrie à ce poste. Ses précédentes fonctions comprennent celles de président et directeur général de Spectrum Solutions, ainsi que des postes de direction chez Z-Medica, Solta Medical et Johnson & Johnson. Il est actuellement président de Champion Manufacturing et LKC Technologies.

Fanning rejoindra à la fois le Comité des nominations et de la gouvernance d'entreprise et le Comité d'audit, portant le nombre total de membres du conseil à huit directeurs. Brent Saunders, président exécutif de BeautyHealth, a souligné l'expertise de Fanning en esthétique médicale et son bilan éprouvé dans la promotion de la croissance mondiale comme des atouts précieux pour les initiatives futures de croissance et de rentabilité de l'entreprise.

BeautyHealth (NASDAQ: SKIN) hat Stephen J. Fanning in seinen Vorstand berufen, mit Wirkung zum 12. Dezember 2024. Fanning, ein Veteran der medizinischen Ästhetik und ehemaliger Vorsitzender von Hydrafacial (2016-2020), bringt umfangreiche Branchenerfahrung in diese Rolle ein. Zu seinen vorherigen Positionen gehören Präsident und CEO von Spectrum Solutions sowie Führungstätigkeiten bei Z-Medica, Solta Medical und Johnson & Johnson. Derzeit ist er Vorsitzender von Champion Manufacturing und LKC Technologies.

Fanning wird sowohl dem Nominierungs- und Unternehmensführungsausschuss als auch dem Prüfungsrat beitreten, sodass die Gesamtzahl der Verwaltungsratsmitglieder auf acht Direktoren anwächst. Brent Saunders, der Executive Chairman von BeautyHealth, hob Fannings Expertise im Bereich medizinische Ästhetik und seine nachgewiesene Erfolgsbilanz bei der globalen Wachstumsförderung als wertvolle Vermögenswerte für das zukünftige Wachstum und die Rentabilitätsinitiativen des Unternehmens hervor.

Positive
  • Appointment of experienced industry veteran with previous company knowledge (former Hydrafacial Chairman)
  • Strategic addition to both Audit and Nominating & Corporate Governance committees
  • Executive with proven track record in driving global growth and profitability
Negative
  • None.

Medical Aesthetics Veteran Brings Extensive Industry Knowledge and Proven Success in Driving Global Growth

LONG BEACH, Calif.--(BUSINESS WIRE)-- The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced the appointment of medical aesthetics veteran, Stephen J. Fanning, to its Board of Directors, effective as of December 12, 2024.

Stephen J. Fanning, Director, The Beauty Health Company (Photo: Business Wire)

Stephen J. Fanning, Director, The Beauty Health Company (Photo: Business Wire)

Mr. Fanning brings decades of global medical aesthetics experience, including serving as Hydrafacial’s Chairman of the Board from 2016 to 2020, prior to the Company’s initial public offering. He was recently President and CEO of Spectrum Solutions, a molecular diagnostics firm, and previously led Z-Medica, boosting sales and EBITDA before its acquisition by Linden Capital. Mr. Fanning also headed Solta Medical, known for Thermage and Fraxel, and held leadership roles at Ocular Sciences and Johnson & Johnson, driving international growth. Today, Mr. Fanning serves as Chairman of the Board for Champion Manufacturing and LKC Technologies.

BeautyHealth Executive Chairman Brent Saunders said: “Stephen’s deep expertise in medical aesthetics, paired with his proven ability to drive global growth will be a tremendous asset on the BeautyHealth Board. From his tenure as Chairman of Hydrafacial LLC, he brings a unique viewpoint that will be instrumental as the Company continues to position itself for consistent growth and profitability and unlock Hydrafacial’s worldwide growth potential.”

Mr. Fanning fills an open seat on the BeautyHealth Board and will join both of the Nominating & Corporate Governance Committee as well as the Audit Committee. Following the appointment, BeautyHealth’s Board will be comprised of eight directors.

About The Beauty Health Company

The Beauty Health Company (NASDAQ: SKIN) is a medtech meets beauty company delivering millions of skin health experiences every year that help consumers reinvent their relationship with their skin, bodies, and self-confidence. Our brands are pioneers: Hydrafacial™ in hydradermabrasion, SkinStylus™ in microneedling, and Keravive™ in scalp health. Together, with our powerful global community of estheticians, partners, and consumers, we are personalizing skin health for all ages, genders, skin tones, and skin types. We are committed to being ever more mindful in how we conduct our business to positively impact our communities and the planet. Find a local provider at https://hydrafacial.com/find-a-provider/ and learn more at beautyhealth.com or LinkedIn.

Source: BeautyHealth

Investors: IR@beautyhealth.com

Media: press@beautyhealth.com

Source: The Beauty Health Company

FAQ

When will Stephen J. Fanning join BeautyHealth's (SKIN) Board of Directors?

Stephen J. Fanning will join BeautyHealth's Board of Directors effective December 12, 2024.

What is Stephen Fanning's previous experience with Hydrafacial and SKIN?

Fanning previously served as Hydrafacial's Chairman of the Board from 2016 to 2020, before the company's initial public offering.

What committees will Fanning serve on at BeautyHealth (SKIN)?

Fanning will serve on both the Nominating & Corporate Governance Committee and the Audit Committee.

How many directors will be on BeautyHealth's (SKIN) board after Fanning's appointment?

Following Fanning's appointment, BeautyHealth's Board will be comprised of eight directors.

What relevant experience does Fanning bring to BeautyHealth (SKIN)?

Fanning brings decades of global medical aesthetics experience, including leadership roles at Spectrum Solutions, Z-Medica, Solta Medical, and Johnson & Johnson.

The Beauty Health Company

NASDAQ:SKIN

SKIN Rankings

SKIN Latest News

SKIN Stock Data

172.53M
113.39M
8.65%
87.03%
6.09%
Household & Personal Products
Surgical & Medical Instruments & Apparatus
Link
United States of America
LONG BEACH